Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.

Calcitonin inhibits both osteoclast formation and bone resorption, and is a primary treatment for patients with hypercalcemia and increased bone turnover. However, the clinical utility of calcitonin is limited because patients become refractory to calcitonin after several days (the calcitonin "escap...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Takahashi, S, Goldring, S, Katz, M, Hilsenbeck, S, Williams, R, Roodman, G D
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295397/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7814611/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI117634
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!